Leads North American business development team and operationsIktos, a drug discovery company, develops innovative artificial Intelligence technologies based on deep learning generative algorithms to accelerate drug discovery projects (from hit discovery through hit-to-lead to lead optimization). Our unique AI is chemistry-driven, inherently leading to synthetically feasible molecules while being truly novel and exploring a huge chemical space. To our knowledge, no other AI technology in the market offers this.- Deep Generative Chemistry modeling (Makya including now Makya 3D) for de novo drug design to expedite structure- and ligand-based hit discovery, hit expansion, and lead optimization projects- Data-driven Retrosynthesis Analysis (Spaya) to explore potential synthetic routes of a given compound and for high-throughput assessment of synthetic accessibility- We now close and accelerate the DMTA loop through our own AI-driven (Ilaka) robotics to synthesize what our AI has designed- In addition to our unmatched AI, we have world-class medicinal and computational chemistry teams who know of course how to use our AI. Give us a target and we will help you under a collaboration framework: hit discovery, hit-to-lead, and lead optimization!

Responsible for the top 50 big global pharmaceutical companies.Brought to Nanome major big pharma companies, such as Sanofi, Novo Nordisk, J&J, Agios Pharmaceuticals, Novozymes, and others, including with global contracts

Revenew identifies and recovers overcharges from suppliers of their multi-billion $ clientsDeveloped sales into big-pharma (Abbott, Pfizer, Sanofi, Novartis, Boehringer-Ingelheim, AstraZeneca, Mylan/Viatris, J&J, GSK, Merck), and other verticals for accounts payable as well as contract compliance reviews & recoveries: big pharma, medical equipment, industrials• Raised contact levels to CPOs, CFOs, Global Heads of Procurement• Signed a contract with a $32 billion big-pharma with potentials of $10 million recoveries• Secured commitment from a $60 billion big-pharma with potentials of $20 million recoveries• Secured other commitments in industrial/energy• Built pipeline with more than 10 large prospects at 50% probability or higher

P&L: $100 million Colorcon is the world leader for coating formulations and excipients for pharmaceutical tablets.Responsible for AstraZeneca, GSK, Merck, Mylan, Pfizer and Sanofi global accounts (more than 1000 products, 150 sites, 50 countries)  Fully and formally re-captured 1st intent at GSK (had been lost more than 5 years ago)o Also negotiated and closed Global Supply, Global R&D CDA and Global Quality Agreement Grew gross margin by 4 points and produced results never obtained before for these accounts Implemented successful price increase effort leveraged through innovative value selling process Quantified values offered to customers Member of the newly created Sales Leadership Teamo Led added value selling quantification process Increased depth, breadth and levels of global accounts contacts resulting in more strategic relationships Used Oracle

P&L: $170 millionCapsugel is the world leader for pharmaceutical capsules.Responsible for global sales of pharmaceutical capsules to all multinational “big-pharma” branded pharmaceutical accounts. Managed and led commercial efforts for 14 global accounts covering about 200 locations worldwide: Abbott, Abbvie, Astellas, AstraZeneca, Bristol-Myers, Boehringer-Ingelheim, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche and Sanofi. In 4 years, increased sales by close to 15% and drastically improved profits Recaptured main Bristol-Myers business for pharmaceutical capsules (UPSA)

P&L: $30 millionResponsible for sales of worldwide technical reticulated polyurethane ester and ether plastics foam under very challenging market dynamics: "great recession", threats from Chinese imports, new European entrant into the US, wide raw material cost fluctuations, growing application conversions away from polyurethane to alternative technologies due to price increases. Brought the sales force to the next level by establishing a more professional sales process, new metrics (KPIs), new goals and tools, while recruiting and training proper staff. Improved the working relationship between sales and manufacturing, and revamped customer service. Main markets were in the US and Canada but sold worldwide. Within a marketplace which shrunk in half, kept sales levels stable since 2007

P&L: $5 million Responsible for worldwide sales & marketing for power plant boiler water chemistry analytical instrumentation (monitoring of hydrazine, copper, ammonia, dissolved oxygen, silica, sodium, etc…). Managed direct sales force, customer service and distributors.  Organically grew annual instruments sales by 30% through steady growth in US and doubling of global sales Fully negotiated and signed private label agreement with Honeywell for China and Asia Set up Waltron Europe

P&L: $230 millionLed a global business development department staffed with 12 product managers and engineers for air driven products such as cylinders/actuators, valves, FRL/ASCs, ARO pumps (diaphragm or piston) and industrial tools (sanders, impact wrenches, jackhammers, manual hoists, grinders) representing about 40,000 SKUs.  Improved domestic gross margin by 3 points by successful price increase design and implementation

P&L: $500 millionManaged marketing for Aggregates, Ready Mix and Asphalt. Led a 10-member marketing department of both this division and the five regions it comprised. Created new multi-region marketing team: pricing and marketing specialists, data warehouse manager Moved organization towards marketing-driven culture and structure contributing to increased profitability

P&L: $450 millionLed worldwide sales & marketing for carbon black (specialty chemicals) to the tire industry. Directed marketing efforts of Managers of Marketing for the Americas, Europe and Asia.  Successfully extended $150 million per year global contract Developed marketing plans for all regions worldwide

P&L: $500 millionAs member of the executive team and change agent, led sales team, for field marketing support, sales & marketing management and for definition of new global and domestic sales and marketing strategies.  Recaptured $20 million of lost business and created the first marketing plans and CRM tools at Phelps Dodge Magnet Wire

Defined new added value messages and trained sales force on new value message and product line

Sold capital equipment plants of up to $70 million

Sold VSA and HPN Systems. Signed first-ever post-combustion onsite VSA system in the US

Product Manager, Services, Houston, TXGrew business from 30 to 200+ accounts

Responsible for the Large Appliances, United States Injection Molding Market, Dow Plastics. Provided technical expertise in thermoplastic resins. Coordinated resin and part development programs with customers. Helped OEMs design parts using thermoplastic resins and assisted injection molders in applying thermoplastic technology.  Prepared marketing analysis and technically qualified resins for $10 million of new sales

Through GE's Chemicals and Materials Management Program, occupied three different application engineering and technical sales positions.